Skip to main content
NCBI home page
The British Journal of General Practice logoLink to The British Journal of General Practice
. 2002 Oct;52(483):818–824.

Secondary prevention of cardiovascular disease: a randomised trial of training in information management, evidence-based medicine, both or neither: the PIER trial.

Julia Langham 1, Helen Tucker 1, David Sloan 1, Jane Pettifer 1, Simon Thom 1, Harry Hemingway 1
PMCID: PMC1316085  PMID: 12392122

Abstract

BACKGROUND: Sub-optimal management of cardiovascular disease (CVD) patients is widespread in primary and secondary care, with risk factors frequently unrecorded or untreated. AIM: To investigate the effectiveness of educational interventions developed in primary care, on recording, prescribing and control of risk factors among all patients recorded by their general practitioner as having CVD. DESIGN OF STUDY: Factorial, duster-randomised controlled trial. SETTING: Primary care teams representing the range of practice development in a geographically defined area in inner London. METHOD: Participating practices were randomly allocated to one of the four intervention groups: information, evidence, both or neither. Interventions were tailored to suit individual practice needs. At a mean of 19 months after baseline, and three months after the end of intervention, practices carried out the follow-up assessment of recording, treatment, and control of risk factors in the same CVD patients. RESULTS: Adequate recording of all three risk factors, found inapproximately a third of patients at baseline, increased non-significantly by 10.5% (95% confidence interval [CI] = 3.9 to 24.9) in the information (versus not information) group and by 6.6% (95% [CI] = 8.9 to 22.0) in the evidence (versus not evidence) group. Factorial improvements in prescribing and control of risk factors tended not to be significant. Adequate recording of an three risk factors showed the greatest improvement in the information plus evidence group (19.9% increase, P for heterogeneity across the four groups < or = 0.001). Mean change from baseline to follow-up within the four intervention groups suggested improvements in the combined information plus evidence group in cholesterol recording (22.5% increase), prescribing of lipid lowering drugs (4.4% increase) and mean cholesterol (0.7 mmol/l decrease). CONCLUSIONS: Adequate risk factor recording did not differ between the information (versus not information) or the evidence (versus not evidence) intervention groups. Combined training in information systems and evidence-based medicine should be considered in the design of future interventions, to improve secondary prevention of CVD.

Full Text

The Full Text of this article is available as a PDF (82.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bland J. M., Kerry S. M. Statistics notes. Weighted comparison of means. BMJ. 1998 Jan 10;316(7125):129–129. doi: 10.1136/bmj.316.7125.129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bradley F., Morgan S., Smith H., Mant D. Preventive care for patients following myocardial infarction. The Wessex Research Network (WReN). Fam Pract. 1997 Jun;14(3):220–226. doi: 10.1093/fampra/14.3.220. [DOI] [PubMed] [Google Scholar]
  3. Brady A. J., Oliver M. A., Pittard J. B. Secondary prevention in 24, 431 patients with coronary heart disease: survey in primary care. BMJ. 2001 Jun 16;322(7300):1463–1463. doi: 10.1136/bmj.322.7300.1463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Campbell N. C., Ritchie L. D., Thain J., Deans H. G., Rawles J. M., Squair J. L. Secondary prevention in coronary heart disease: a randomised trial of nurse led clinics in primary care. Heart. 1998 Nov;80(5):447–452. doi: 10.1136/hrt.80.5.447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Campbell N. C., Thain J., Deans H. G., Ritchie L. D., Rawles J. M. Secondary prevention in coronary heart disease: baseline survey of provision in general practice. BMJ. 1998 May 9;316(7142):1430–1434. doi: 10.1136/bmj.316.7142.1430. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Campbell N. C., Thain J., Deans H. G., Ritchie L. D., Rawles J. M., Squair J. L. Secondary prevention clinics for coronary heart disease: randomised trial of effect on health. BMJ. 1998 May 9;316(7142):1434–1437. doi: 10.1136/bmj.316.7142.1434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Capewell S., Morrison C. E., McMurray J. J. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart. 1999 Apr;81(4):380–386. doi: 10.1136/hrt.81.4.380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cupples M. E., McKnight A. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk. BMJ. 1994 Oct 15;309(6960):993–996. doi: 10.1136/bmj.309.6960.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Donald A., Donner A. Adjustments to the Mantel-Haenszel chi-square statistic and odds ratio variance estimator when the data are clustered. Stat Med. 1987 Jun;6(4):491–499. doi: 10.1002/sim.4780060408. [DOI] [PubMed] [Google Scholar]
  10. Ebrahim S., Davey Smith G., McCabe C., Payne N., Pickin M., Sheldon T. A., Lampe F., Sampson F., Ward S., Wannamethee G. What role for statins? A review and economic model. Health Technol Assess. 1999;3(19):i-iv, 1-91. [PubMed] [Google Scholar]
  11. Feder G., Griffiths C., Eldridge S., Spence M. Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): randomised controlled trial. BMJ. 1999 Jun 5;318(7197):1522–1526. doi: 10.1136/bmj.318.7197.1522. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hunink M. G., Goldman L., Tosteson A. N., Mittleman M. A., Goldman P. A., Williams L. W., Tsevat J., Weinstein M. C. The recent decline in mortality from coronary heart disease, 1980-1990. The effect of secular trends in risk factors and treatment. JAMA. 1997 Feb 19;277(7):535–542. [PubMed] [Google Scholar]
  13. Jarman B. Underprivileged areas: validation and distribution of scores. Br Med J (Clin Res Ed) 1984 Dec 8;289(6458):1587–1592. doi: 10.1136/bmj.289.6458.1587. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jolly K., Bradley F., Sharp S., Smith H., Thompson S., Kinmonth A. L., Mant D. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: final results of the Southampton heart integrated care project (SHIP). The SHIP Collaborative Group. BMJ. 1999 Mar 13;318(7185):706–711. doi: 10.1136/bmj.318.7185.706. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Moher M., Yudkin P., Wright L., Turner R., Fuller A., Schofield T., Mant D. Cluster randomised controlled trial to compare three methods of promoting secondary prevention of coronary heart disease in primary care. BMJ. 2001 Jun 2;322(7298):1338–1338. doi: 10.1136/bmj.322.7298.1338. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pringle M. Preventing ischaemic heart disease in one general practice: from one patient, through clinical audit, needs assessment, and commissioning into quality improvement. BMJ. 1998 Oct 24;317(7166):1120–1124. doi: 10.1136/bmj.317.7166.1120. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ramsay L., Williams B., Johnston G., MacGregor G., Poston L., Potter J., Poulter N., Russell G. Guidelines for management of hypertension: report of the third working party of the British Hypertension Society. J Hum Hypertens. 1999 Sep;13(9):569–592. doi: 10.1038/sj.jhh.1000917. [DOI] [PubMed] [Google Scholar]
  18. Sacks F. M., Pfeffer M. A., Moye L. A., Rouleau J. L., Rutherford J. D., Cole T. G., Brown L., Warnica J. W., Arnold J. M., Wun C. C. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996 Oct 3;335(14):1001–1009. doi: 10.1056/NEJM199610033351401. [DOI] [PubMed] [Google Scholar]
  19. Shepherd J., Cobbe S. M., Ford I., Isles C. G., Lorimer A. R., MacFarlane P. W., McKillop J. H., Packard C. J. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med. 1995 Nov 16;333(20):1301–1307. doi: 10.1056/NEJM199511163332001. [DOI] [PubMed] [Google Scholar]
  20. Tunstall-Pedoe H., Vanuzzo D., Hobbs M., Mähönen M., Cepaitis Z., Kuulasmaa K., Keil U. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet. 2000 Feb 26;355(9205):688–700. doi: 10.1016/s0140-6736(99)11181-4. [DOI] [PubMed] [Google Scholar]
  21. Ukoumunne O. C., Gulliford M. C., Chinn S., Sterne J. A., Burney P. G., Donner A. Methods in health service research. Evaluation of health interventions at area and organisation level. BMJ. 1999 Aug 7;319(7206):376–379. doi: 10.1136/bmj.319.7206.376. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of General Practice are provided here courtesy of Royal College of General Practitioners

RESOURCES